NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.04, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Earnings Guidance